Condition: Pulmonary Hypertension · Pulmonary Arterial Hypertension · Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) · Sponsor: Rutgers, The State University of New Jersey
The goal of this observational study is to learn more about how genes impact the risk of pulmonary hypertension. Anyone 18 or older living in the US is eligible, and a diagnosis of PH is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.
This description comes directly from the study's public registry record.
Tara Matise, Ph.D. · 848-445-3125 · rugcc-ph@rutgers.edu
Steve Buyske, Ph.D. · rugcc-ph@rutgers.edu
Always discuss trial participation with your own doctor first.
| Rutgers University, Piscataway, New Jersey 08854 | Piscataway, New Jersey, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07217522